IOmx Therapeutics AG

Allemagne


Commandez votre montre hebdomadaire IOmx Therapeutics AG
Quantité totale PI 54
Rang # Quantité totale PI 25 979
Note d'activité PI 2,5/5.0    39
Rang # Activité PI 19 117
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

14 5
9 1
18 2
5
 
Dernier brevet 2025 - A synthesis scheme and procedure...
Premier brevet 2017 - Or10h1 antigen binding proteins ...
Dernière marque 2024 - IOMX
Première marque 2016 - IOMX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Chemical preparations for scientific and industrial purposes; genetically engineered polypeptides...
P/S Chemical preparations for scientific and industrial purposes; genetically engineered polypeptide...
Invention Heterocyclic kinase inhibitors and uses thereof. The invention relates to kinase inhibitors, in ...
P/S Chemical preparations for scientific and industrial purposes; Polypeptides and proteins produced ...
Invention Platform technology for the identification of modulators of immune effector cell function. [1] Th...
Invention Combinations of halogenated heterocyclic kinase inhibitors and vegfr inhibitors. The present inve...
2023 Invention Cross-specific antigen binding proteins (abp) targeting leukocyte immunoglobulin-like receptor su...
Invention Combination therapies based on pd-1 inhibitors and sik3 inhibitors. The invention relates to a u...
Invention Combination therapies based on pd-1 inhibitors and sik3 inhibitors. The invention relates to a us...
Invention Sik3 inhibitors for treating diseases resistant to death receptor signalling. The invention is b...
Invention Sik3 inhibitors for treating diseases resistant to death receptor signalling. [1] The invention i...
2022 Invention A synthesis scheme and procedures for preparing a sik3 inhibitor and intermediates thereof. The ...
Invention A synthesis scheme and procedures for preparing a sik3 inhibitor and intermediates thereof. The p...
P/S Chemical preparations for scientific purposes, other than for medical or veterinary use; chemica...
P/S Chemical preparations for scientific purposes, other than for medical or veterinary use; chemical...
2021 P/S Chemical substances, chemical materials and chemical preparations, and natural elements; Chemical...
Invention Antibodies binding igc2 of igsf11 (vsig3) and uses thereof. The invention is based on the surpris...
Invention Intracellular kinase associated with resistance against t-cell mediated cytotoxicity, and uses th...
Invention Bicyclic kinase inhibitors and uses thereof. The invention relates to kinase inhibitors, in part...
Invention Bicyclic kinase inhibitors and uses thereof. The invention relates to kinase inhibitors, in parti...
Invention Halogenated-heteroaryl and other heterocyclic kinase inhibitors, and uses thereof. The invention...
Invention Halogenated-heteroaryl and other heterocyclic kinase inhibitors, and uses thereof. inter-aliainte...
2020 Invention Antibodies binding igv of igsf11 (vsig3) and uses thereof. The invention is based on the surpris...
Invention Antibodies binding igc2 of igsf11 (vsig3) and uses thereof. The invention is based on the surpri...
Invention Antibodies binding igv of igsf11 (vsig3) and uses thereof. The invention is based on the surprisi...
2019 Invention Heterocyclic kinase inhibitors and uses thereof. The invention relates to kinase inhibitors, in p...
Invention Dasatinib and another 5-thiazolecarboxamide kinase inhibitor, and uses thereof. The invention re...
Invention Dasatinib and another 5-thiazolecarboxamide kinase inhibitor, and uses thereof. The invention rel...
Invention 5-thiazolecarboxamide kinase inhibitor and uses thereof. The invention relates to a kinase inhibi...
Invention A 5-thiazolecarboxamide kinase inhibitor and uses thereof. The invention relates to a kinase inhi...
Invention Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance ...
2018 Invention Intracellular kinase associated with resistance against anti-tumour immune responses, and uses th...
P/S Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulation...
P/S [ Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulat...
2017 Invention Or10h1 antigen binding proteins and uses thereof. The invention provides antigen binding protein...
Invention Or10h1 antigen binding proteins and uses thereof. The invention provides antigen binding proteins...
P/S Pharmaceuticals, medical and veterinary preparations; Pharmaceutical preparations and formulation...
2016 P/S Research and development of pharmaceutical and therapeutic preparations in the field of oncology ...
P/S Pharmaceutical preparations and therapeutic preparations in the nature of medications and therape...